Spain· ES:1221662001
PYRUKYND 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
A mitapivat product containing mitapivat, registered in Spain by Agios Netherlands B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
Where it is registered
Mitapivat is registered in 11 of 19 countries.
Countries holding a registration under ATC B06AX04 (mitapivat), each read from that country’s own register.
- This record: Spain, from AEMPS CIMA (Spain)
- 7 of them publish a price we can compare per daily dose
Mitapivat · ATC B06AX04
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- mitapivat
- Manufacturer
- Agios Netherlands B.V.
- Country
- Spain (ES)
- ATC code
- B06AX04
- ATC class
- Mitapivat
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 8, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mitapivat in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesPYRUKYNDAgios Pharmaceuticals, Inc.
- CzechiaPYRUKYNDAgios Netherlands B.V., Amsterdam
- BelgiumPyrukynd 5 mgAgios Netherlands
- IrelandPyrukynd 5 mg film-coated tabletsAgios Netherlands B.V.
- IcelandPyrukyndAgios Netherlands B.V.
- NetherlandsPyrukynd 5 mg, filmomhulde tablettenAgios Netherlands B.V.
- PolandPyrukyndAgios Netherlands B.V.
- SwedenPyrukynd 5 mg Filmdragerad tablettAgios Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Pyrukynd
- Liechtenstein · Pyrukynd
- Norway · Pyrukynd
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/759f6fd5-3d07-4f0f-9093-d660e405b524 GET /v1/drugs/759f6fd5-3d07-4f0f-9093-d660e405b524?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":1780648266000}",
"nregistro": "1221662001",
"substance": "mitapivat"
}See everything about mitapivat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.